IL61038A - 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them - Google Patents

15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them

Info

Publication number
IL61038A
IL61038A IL61038A IL6103880A IL61038A IL 61038 A IL61038 A IL 61038A IL 61038 A IL61038 A IL 61038A IL 6103880 A IL6103880 A IL 6103880A IL 61038 A IL61038 A IL 61038A
Authority
IL
Israel
Prior art keywords
sulfonamidoprostaglandin
derivatives
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL61038A
Other languages
English (en)
Other versions
IL61038A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL61038A0 publication Critical patent/IL61038A0/xx
Publication of IL61038A publication Critical patent/IL61038A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL61038A 1979-09-17 1980-09-15 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them IL61038A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/076,520 US4232173A (en) 1979-09-17 1979-09-17 15-Sulfonamidoprostaglandin derivatives

Publications (2)

Publication Number Publication Date
IL61038A0 IL61038A0 (en) 1980-11-30
IL61038A true IL61038A (en) 1983-12-30

Family

ID=22132532

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61038A IL61038A (en) 1979-09-17 1980-09-15 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4232173A (xx)
EP (1) EP0025687B1 (xx)
JP (1) JPS5951938B2 (xx)
KR (1) KR840000964B1 (xx)
AR (1) AR225776A1 (xx)
AT (1) ATE1858T1 (xx)
AU (1) AU518068B2 (xx)
CA (1) CA1153368A (xx)
DE (1) DE3061160D1 (xx)
DK (1) DK392580A (xx)
ES (1) ES8106489A1 (xx)
FI (1) FI68615C (xx)
GR (1) GR70288B (xx)
IE (1) IE50266B1 (xx)
IL (1) IL61038A (xx)
PH (1) PH15098A (xx)
PT (1) PT71807B (xx)
YU (1) YU236180A (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
JPS63207015A (ja) * 1987-02-23 1988-08-26 株式会社日立製作所 遮断器装置
JPS6429564A (en) * 1987-07-25 1989-01-31 Oyo Kikaku Kk Common joist mechanism
US5387608A (en) * 1993-08-17 1995-02-07 Allergan, Inc. Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
US5607415A (en) * 1994-08-18 1997-03-04 Kimberly-Clark Corporation Flexible absorbent article

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835179A (en) * 1972-07-24 1974-09-10 American Cyanamid Co Novel 15-substituted prostanoic acids and esters
US4033996A (en) * 1973-04-25 1977-07-05 Merck & Co., Inc. 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
EP0025687B1 (en) 1982-11-24
PT71807B (en) 1981-07-02
IE801927L (en) 1981-03-17
KR840000964B1 (ko) 1984-07-02
FI68615B (fi) 1985-06-28
IE50266B1 (en) 1986-03-19
PH15098A (en) 1982-08-10
JPS5651448A (en) 1981-05-09
DE3061160D1 (en) 1982-12-30
KR830003415A (ko) 1983-06-20
AU6243680A (en) 1981-03-26
GR70288B (xx) 1982-09-03
PT71807A (en) 1980-10-01
FI802904A (fi) 1981-03-18
ATE1858T1 (de) 1982-12-15
EP0025687A1 (en) 1981-03-25
US4232173A (en) 1980-11-04
DK392580A (da) 1981-03-18
IL61038A0 (en) 1980-11-30
CA1153368A (en) 1983-09-06
JPS5951938B2 (ja) 1984-12-17
FI68615C (fi) 1985-10-10
ES495101A0 (es) 1981-08-16
AR225776A1 (es) 1982-04-30
ES8106489A1 (es) 1981-08-16
YU236180A (en) 1983-01-21
AU518068B2 (en) 1981-09-10

Similar Documents

Publication Publication Date Title
NZ192653A (en) 4-substituted piperidino-alkanol derivatives and pharmaceutical compositions containing them
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
DE3061551D1 (en) Diphosphonate or phosphate-phosphonate derivatives and pharmaceutical compositions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
MY8700186A (en) 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
GB2046259B (en) Amino-alcohol derivatives and pharmaceutical compositions containing them
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
PH16243A (en) Sugar derivatives and pharmaceutical composition containing same
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL61117A (en) 2beta-acetoxymethyl-penam compounds and pharmaceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
GB2010261B (en) Phenoxyalkanolamine derivatives the preparation thereof and pharmaceutical compositions containing them
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
IL60695A (en) Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them
IL60332A0 (en) Pyridylaminotriazole derivatives and pharmaceutical compositions containing them
IL60040A0 (en) Imidazole derivatives and pharmaceutical compositions containing them
PH15436A (en) 4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions thereof
IL61626A0 (en) 6-pyridinyl-pyridazine derivatives and pharmalceutical compositions containing them
NZ194122A (en) Acylaminobenzoic acid derivatives and pharmaceutical compositions